МЭЙТС Шэрон (US),ЛИ Пэн (US),УЭННОГЛ Лоуренс П. (US),ДЭВИС Роберт (US)
申请号：
RU2016143357
公开号：
RU2016143357A
申请日:
2015.04.03
申请国别(地区):
RU
年份:
2018
代理人:
摘要：
The invention relates to particular substituted heterocycle fused gamma-carbolines, their prodrugs, in free, solid, pharmaceutically acceptable salt and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving 5-HT2A receptor, serotonin transporter (SERT) and/or pathways involving dopamine D1/D2 receptor signaling systems, and/or the treatment of residual symptoms.
